The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses

The many roles of chemokines and chemokine receptors in inflammation

Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523

Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis

van der Fits, L., Mourits, S., Voerman, J. S. A., Kant, M., Boon, L., Laman, J. D., Cornelissen, F., Mus, A.-M., Florencia, E., Prens, E. P., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802999 · Cited by 2,176

Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide

Lande, R., Gregorio, J., Facchinetti, V., Chatterjee, B., Wang, Y.-H., Homey, B., Cao, W., Wang, Y.-H., Su, B., Nestle, F. O., et al. (2007) · Nature · doi:10.1038/nature06116 · Cited by 1,910

Risk of myocardial infarction in patients with psoriasis

Gelfand, J. M., Neimann, A. L., Shin, D. B., Wang, X., Margolis, D. J., & Troxel, A. B. (2006) · JAMA · doi:10.1001/jama.296.14.1735 · Cited by 1,899

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

Leonardi, C. L., Kimball, A. B., Papp, K. A., Yeilding, N., Guzzo, C., Wang, Y., Li, S., Dooley, L. T., & Gordon, K. B. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60725-4 · Cited by 1,874

β-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6

Yang, D., Chertov, O., Bykovskaia, S. N., Chen, Q., Buffo, M. J., Shogan, J., Anderson, M., Schröder, J. M., Wang, J. M., Howard, O. M. Z., et al. (1999) · Science · doi:10.1126/science.286.5439.525 · Cited by 1,809

Pathogenesis and therapy of psoriasis

Lowes, M. A., Bowcock, A. M., & Krueger, J. G. (2007) · Nature · doi:10.1038/nature05663 · Cited by 1,778

Structure and signalling in the IL-17 receptor family

Gaffen, S. L. (2009) · Nature reviews. Immunology · doi:10.1038/nri2586 · Cited by 1,475

Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock

Vogl, T., Tenbrock, K., Ludwig, S., Leukert, N., Ehrhardt, C., van Zoelen, M. A. D., Nacken, W., Foell, D., van der Poll, T., Sorg, C., et al. (2007) · Nature Medicine · doi:10.1038/nm1638 · Cited by 1,418

Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways

for the Collaborative Association Study of Psoriasis, Nair, R. P., Duffin, K. C., Helms, C., Ding, J., Stuart, P. E., Goldgar, D., Gudjonsson, J. E., Li, Y., Tejasvi, T., et al. (2009) · Nature Genetics · doi:10.1038/ng.311 · Cited by 1,409

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

Papp, K. A., Langley, R. G., Lebwohl, M., Krueger, G. G., Szapary, P., Yeilding, N., Guzzo, C., Hsu, M.-C., Wang, Y., Li, S., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60726-6 · Cited by 1,361

Etanercept as Monotherapy in Patients with Psoriasis

Leonardi, C. L., Powers, J. L., Matheson, R. T., Goffe, B. S., Zitnik, R., Wang, A., & Gottlieb, A. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030409 · Cited by 1,175

A Large-Scale Genetic Association Study Confirms IL12B and Leads to the Identification of IL23R as Psoriasis-Risk Genes

Cargill, M., Schrodi, S. J., Chang, M., Garcia, V. E., Brandon, R., Callis, K. P., Matsunami, N., Ardlie, K. G., Civello, D., Catanese, J. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/511051 · Cited by 1,086

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial

Tyring, S., Gottlieb, A., Papp, K., Gordon, K., Leonardi, C., Wang, A., Lalla, D., Woolley, M., Jahreis, A., Zitnik, R., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(05)67763-x · Cited by 1,069

Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial

Reich, K., Nestle, F. O., Papp, K., Ortonne, J.-P., Evans, R., Guzzo, C., Li, S., Dooley, L. T., & Griffiths, C. E. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67566-6 · Cited by 1,045

Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin Inflammation

Cai, Y., Shen, X., Ding, C., Qi, C., Li, K., Li, X., Jala, V. R., Zhang, H.-G., Wang, T., Zheng, J., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.08.001 · Cited by 1,026

Interleukin-36–Receptor Antagonist Deficiency and Generalized Pustular Psoriasis

Marrakchi, S., Guigue, P., Renshaw, B. R., Puel, A., Pei, X.-Y., Fraitag, S., Zribi, J., Bal, E., Cluzeau, C., Chrabieh, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1013068 · Cited by 998

Psoriasis − epidemiology and clinical spectrum

Christophers, E. (2001) · Clinical and Experimental Dermatology · doi:10.1046/j.1365-2230.2001.00832.x · Cited by 972

Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis

Papp, K. A., Leonardi, C., Menter, A., Ortonne, J.-P., Krueger, J. G., Kricorian, G., Aras, G., Li, J., Russell, C. B., Thompson, E. H. Z., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109017 · Cited by 941

Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis

Leonardi, C., Matheson, R., Zachariae, C., Cameron, G., Li, L., Edson-Heredia, E., Braun, D., & Banerjee, S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109997 · Cited by 936

Mast Cells and Neutrophils Release IL-17 through Extracellular Trap Formation in Psoriasis

Lin, A. M., Rubin, C. J., Khandpur, R., Wang, J. Y., Riblett, M., Yalavarthi, S., Villanueva, E. C., Shah, P., Kaplan, M. J., & Bruce, A. T. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100123 · Cited by 906

Increased Expression of Interleukin 23 p19 and p40 in Lesional Skin of Patients with Psoriasis Vulgaris

Lee, E., Trepicchio, W. L., Oestreicher, J. L., Pittman, D., Wang, F., Chamian, F., Dhodapkar, M., & Krueger, J. G. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20030451 · Cited by 899

Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease

Onishi, R. M., & Gaffen, S. L. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03240.x · Cited by 894

Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial

Menter, A., Tyring, S. K., Gordon, K., Kimball, A. B., Leonardi, C. L., Langley, R. G., Strober, B. E., Kaul, M., Gu, Y., Okun, M., et al. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.09.010 · Cited by 889

Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis

Hueber, W., Patel, D. D., Dryja, T., Wright, A. M., Koroleva, I., Bruin, G., Antoni, C., Draelos, Z., Gold, M. H., the Psoriasis Study Group, et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001107 · Cited by 860

Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways

Nograles, K. E., Zaba, L. C., Guttman-Yassky, E., Fuentes-Duculan, J., Suárez-Fariñas, M., Cardinale, I., Khatcherian, A., Gonzalez, J., Pierson, K. C., White, T. R., et al. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08769.x · Cited by 804

Self-RNA–antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8

Ganguly, D., Chamilos, G., Lande, R., Gregorio, J., Meller, S., Facchinetti, V., Homey, B., Barrat, F. J., Zal, T., & Gilliet, M. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090480 · Cited by 740

Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION)

Saurat, J. ‐., Stingl, G., Dubertret, L., Papp, K. A., Langley, R. G. B., Ortonne, J. ‐., Unnebrink, K., Kaul, M., Camez, A., & for the CHAMPION Study Investigators (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08315.x · Cited by 728

Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions

Davidovici, B. B., Sattar, N., Jörg, P. C., Puig, L., Emery, P., Barker, J. N., van de Kerkhof, P., Ståhle, M., Nestle, F. O., Girolomoni, G., et al. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.103 · Cited by 711

Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database

Mehta, N. N., Azfar, R. S., Shin, D. B., Neimann, A. L., Troxel, A. B., & Gelfand, J. M. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp567 · Cited by 706

A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction

Papp, K. A., Tyring, S., Lahfa, M., Prinz, J., Griffiths, C. E. M., Nakanishi, A. M., Zitnik, R., van de Kerkhof, P. C. M., & the Etanercept Psoriasis Study Group (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06688.x · Cited by 693

Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis

Chiricozzi, A., Guttman-Yassky, E., Suárez-Fariñas, M., Nograles, K. E., Tian, S., Cardinale, I., Chimenti, S., & Krueger, J. G. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.340 · Cited by 686

Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses

Zaba, L. C., Cardinale, I., Gilleaudeau, P., Sullivan-Whalen, M., Suárez-Fariñas, M., Fuentes-Duculan, J., Novitskaya, I., Khatcherian, A., Bluth, M. J., Lowes, M. A., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20071094 · Cited by 676

CD27 is a thymic determinant of the balance between interferon-γ- and interleukin 17–producing γδ T cell subsets

Ribot, J. C., deBarros, A., Pang, D. J., Neves, J. F., Peperzak, V., Roberts, S. J., Girardi, M., Borst, J., Hayday, A. C., Pennington, D. J., et al. (2009) · Nature Immunology · doi:10.1038/ni.1717 · Cited by 628

Orchestrating the orchestrators: chemokines in control of T cell traffic

Bromley, S. K., Mempel, T. R., & Luster, A. D. (2008) · Nature Immunology · doi:10.1038/ni.f.213 · Cited by 593

Infliximab induction therapy for patients with severe plaque-type psoriasis: A randomized, double-blind, placebo-controlled trial

Gottlieb, A. B., Evans, R., Li, S., Dooley, L. T., Guzzo, C. A., Baker, D., Bala, M., Marano, C. W., & Menter, A. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.02.021 · Cited by 581

Mutations in IL36RN/IL1F5 Are Associated with the Severe Episodic Inflammatory Skin Disease Known as Generalized Pustular Psoriasis

Onoufriadis, A., Simpson, M. A., Pink, A. E., Di Meglio, P., Smith, C. H., Pullabhatla, V., Knight, J., Spain, S. L., Nestle, F. O., Burden, A. D., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.07.022 · Cited by 529

A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis

Menter, A., Feldman, S. R., Weinstein, G. D., Papp, K., Evans, R., Guzzo, C., Li, S., Dooley, L. T., Arnold, C., & Gottlieb, A. B. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.07.017 · Cited by 516

Rorγt+ innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in mice

Pantelyushin, S., Haak, S., Ingold, B., Kulig, P., Heppner, F. L., Navarini, A. A., & Becher, B. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61862 · Cited by 512

Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: Double-blind, randomized controlled trial and open-label extension study

Gordon, K. B., Langley, R. G., Leonardi, C., Toth, D., Menter, M. A., Kang, S., Heffernan, M., Miller, B., Hamlin, R., Lim, L., et al. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.05.027 · Cited by 510

The Majority of Epidermal T Cells in Psoriasis Vulgaris Lesions can Produce Type 1 Cytokines, Interferon-γ, Interleukin-2, and Tumor Necrosis Factor-α, Defining TC1 (Cytotoxic T Lymphocyte) and TH1 Effector Populations:1 a Type 1 Differentiation Bias is also Measured in Circulating Blood T Cells in Psoriatic Patients

Austin, L. M., Ozawa, M., Kikuchi, T., Walters, I. B., & Krueger, J. G. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00749.x · Cited by 485

Induction of IL-17+ T Cell Trafficking and Development by IFN-γ: Mechanism and Pathological Relevance in Psoriasis

Kryczek, I., Bruce, A. T., Gudjonsson, J. E., Johnston, A., Aphale, A., Vatan, L., Szeliga, W., Wang, Y., Liu, Y., Welling, T. H., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4733 · Cited by 470

Increase in TNF-α and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)

Lowes, M. A., Chamian, F., Abello, M. V., Fuentes-Duculan, J., Lin, S.-L., Nussbaum, R., Novitskaya, I., Carbonaro, H., Cardinale, I., Kikuchi, T., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509736102 · Cited by 456

LY2439821, a humanized anti–interleukin‐17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double‐blind, placebo‐controlled, proof‐of‐concept study

Genovese, M. C., Van den Bosch, F., Roberson, S. A., Bojin, S., Biagini, I. M., Ryan, P., & Sloan‐Lancaster, J. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27334 · Cited by 451

Psoriasis Is Characterized by Accumulation of Immunostimulatory and Th1/Th17 Cell-Polarizing Myeloid Dendritic Cells

Zaba, L. C., Fuentes-Duculan, J., Eungdamrong, N. J., Abello, M. V., Novitskaya, I., Pierson, K. C., Gonzalez, J., Krueger, J. G., & Lowes, M. A. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.194 · Cited by 442

Cytosolic DNA Triggers Inflammasome Activation in Keratinocytes in Psoriatic Lesions

Dombrowski, Y., Peric, M., Koglin, S., Kammerbauer, C., Göß, C., Anz, D., Simanski, M., Gläser, R., Harder, J., Hornung, V., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002001 · Cited by 431

PSORS2 Is Due to Mutations in CARD14

Jordan, C. T., Cao, L., Roberson, E. D. O., Pierson, K. C., Yang, C.-F., Joyce, C. E., Ryan, C., Duan, S., Helms, C. A., Liu, Y., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.03.012 · Cited by 416

Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis

Capon, F., Di Meglio, P., Szaub, J., Prescott, N. J., Dunster, C., Baumber, L., Timms, K., Gutin, A., Abkevic, V., Burden, A. D., et al. (2007) · Human Genetics · doi:10.1007/s00439-007-0397-0 · Cited by 408

New insights of T cells in the pathogenesis of psoriasis

Cai, Y., Fleming, C., & Yan, J. (2012) · Cellular & Molecular Immunology · doi:10.1038/cmi.2012.15 · Cited by 389

IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis

Krueger, J. G., Fretzin, S., Suárez-Fariñas, M., Haslett, P. A., Phipps, K. M., Cameron, G. S., McColm, J., Katcherian, A., Cueto, I., White, T., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.04.024 · Cited by 383

Rare and Common Variants in CARD14, Encoding an Epidermal Regulator of NF-kappaB, in Psoriasis

Jordan, C. T., Cao, L., Roberson, E. D. O., Duan, S., Helms, C. A., Nair, R. P., Duffin, K. C., Stuart, P. E., Goldgar, D., Hayashi, G., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.03.013 · Cited by 356

Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation

Blumberg, H., Dinh, H., Trueblood, E. S., Pretorius, J., Kugler, D., Weng, N., Kanaly, S. T., Towne, J. E., Willis, C. R., Kuechle, M. K., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070157 · Cited by 348

Interleukin-36 (IL-36) Ligands Require Processing for Full Agonist (IL-36α, IL-36β, and IL-36γ) or Antagonist (IL-36Ra) Activity

Towne, J. E., Renshaw, B. R., Douangpanya, J., Lipsky, B. P., Shen, M., Gabel, C. A., & Sims, J. E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.267922 · Cited by 326

Identification of a Novel Proinflammatory Human Skin-Homing Vγ9Vδ2 T Cell Subset with a Potential Role in Psoriasis

Laggner, U., Di Meglio, P., Perera, G. K., Hundhausen, C., Lacy, K. E., Ali, N., Smith, C. H., Hayday, A. C., Nickoloff, B. J., & Nestle, F. O. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100804 · Cited by 320

Resident and “Inflammatory” Dendritic Cells in Human Skin

Zaba, L. C., Krueger, J. G., & Lowes, M. A. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.225 · Cited by 319

IL-1F5, -F6, -F8, and -F9: A Novel IL-1 Family Signaling System That Is Active in Psoriasis and Promotes Keratinocyte Antimicrobial Peptide Expression

Johnston, A., Xing, X., Guzman, A. M., Riblett, M., Loyd, C. M., Ward, N. L., Wohn, C., Prens, E. P., Wang, F., Maier, L. E., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003162 · Cited by 319

Type I Interferon: Potential Therapeutic Target for Psoriasis?

Yao, Y., Richman, L., Morehouse, C., de los Reyes, M., Higgs, B. W., Boutrin, A., White, B., Coyle, A., Krueger, J., Kiener, P. A., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002737 · Cited by 308

Expanding the Psoriasis Disease Profile: Interrogation of the Skin and Serum of Patients with Moderate-to-Severe Psoriasis

Suárez-Fariñas, M., Li, K., Fuentes-Duculan, J., Hayden, K., Brodmerkel, C., & Krueger, J. G. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.184 · Cited by 305

Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes

Zaba, L. C., Suárez-Fariñas, M., Fuentes-Duculan, J., Nograles, K. E., Guttman-Yassky, E., Cardinale, I., Lowes, M. A., & Krueger, J. G. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.08.046 · Cited by 303

Psoriasis and metabolic disease: epidemiology and pathophysiology

Azfar, R. S., & Gelfand, J. M. (2008) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3283031c99 · Cited by 297

Immunosurveillance and Immunoregulation by γδ T Cells

Girardi, M. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700003 · Cited by 287

IL-22 Is Required for Imiquimod-Induced Psoriasiform Skin Inflammation in Mice

Van Belle, A. B., de Heusch, M., Lemaire, M. M., Hendrickx, E., Warnier, G., Dunussi-Joannopoulos, K., Fouser, L. A., Renauld, J.-C., & Dumoutier, L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102224 · Cited by 287

Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and ‘Type 1’ inflammatory gene expression

Lew, W., Bowcock, A. M., & Krueger, J. G. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.03.006 · Cited by 284

A Subpopulation of CD163-Positive Macrophages Is Classically Activated in Psoriasis

Fuentes-Duculan, J., Suárez-Fariñas, M., Zaba, L. C., Nograles, K. E., Pierson, K. C., Mitsui, H., Pensabene, C. A., Kzhyshkowska, J., Krueger, J. G., & Lowes, M. A. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.165 · Cited by 282

Cutting Edge: Identification of a Motile IL-17–Producing γδ T Cell Population in the Dermis

Gray, E. E., Suzuki, K., & Cyster, J. G. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100427 · Cited by 263

The IL23R R381Q Gene Variant Protects against Immune-Mediated Diseases by Impairing IL-23-Induced Th17 Effector Response in Humans

Di Meglio, P., Di Cesare, A., Laggner, U., Chu, C.-C., Napolitano, L., Villanova, F., Tosi, I., Capon, F., Trembath, R. C., Peris, K., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017160 · Cited by 262

Antimicrobial peptides in the pathogenesis of psoriasis

MORIZANE, S., & GALLO, R. L. (2012) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2011.01483.x · Cited by 237

Psoriasis genetics: breaking the barrier

Roberson, E. D. O., & Bowcock, A. M. (2010) · Trends in Genetics · doi:10.1016/j.tig.2010.06.006 · Cited by 237

Systemic and Vascular Inflammation in Patients With Moderate to Severe Psoriasis as Measured by [18F]-Fluorodeoxyglucose Positron Emission Tomography –Computed Tomography (FDG-PET/CT): A Pilot Study

Mehta, N. N. (2011) · Archives of Dermatology · doi:10.1001/archdermatol.2011.119 · Cited by 223

Evaluation of the Psoriasis Transcriptome across Different Studies by Gene Set Enrichment Analysis (GSEA)

Suárez-Fariñas, M., Lowes, M. A., Zaba, L. C., & Krueger, J. G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010247 · Cited by 194

Meta-Analysis Derived (MAD) Transcriptome of Psoriasis Defines the “Core” Pathogenesis of Disease

Tian, S., Krueger, J. G., Li, K., Jabbari, A., Brodmerkel, C., Lowes, M. A., & Suárez-Fariñas, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044274 · Cited by 183

The Th17 cytokine IL‐22 induces IL‐20 production in keratinocytes: A novel immunological cascade with potential relevance in psoriasis

Wolk, K., Witte, E., Warszawska, K., Schulze‐Tanzil, G., Witte, K., Philipp, S., Kunz, S., Döcke, W., Asadullah, K., Volk, H., et al. (2009) · European Journal of Immunology · doi:10.1002/eji.200939687 · Cited by 181

An Alternative Pathway of Imiquimod-Induced Psoriasis-Like Skin Inflammation in the Absence of Interleukin-17 Receptor A Signaling

El Malki, K., Karbach, S. H., Huppert, J., Zayoud, M., Reißig, S., Schüler, R., Nikolaev, A., Karram, K., Münzel, T., Kuhlmann, C. R. W., et al. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.318 · Cited by 174

Identification of Cellular Pathways of “Type 1,” Th17 T Cells, and TNF- and Inducible Nitric Oxide Synthase-Producing Dendritic Cells in Autoimmune Inflammation through Pharmacogenomic Study of Cyclosporine A in Psoriasis

Haider, A. S., Lowes, M. A., Suárez-Fariñas, M., Zaba, L. C., Cardinale, I., Khatcherian, A., Novitskaya, I., Wittkowski, K. M., & Krueger, J. G. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1913 · Cited by 173

Chemotactic Activity of S100A7 (Psoriasin) Is Mediated by the Receptor for Advanced Glycation End Products and Potentiates Inflammation with Highly Homologous but Functionally Distinct S100A15

Wolf, R., Howard, O. M. Z., Dong, H.-F., Voscopoulos, C., Boeshans, K., Winston, J., Divi, R., Gunsior, M., Goldsmith, P., Ahvazi, B., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.2.1499 · Cited by 173

A Phase III, Randomized, Controlled Trial of the Fully Human IL-12/23 mAb Briakinumab in Moderate-to-Severe Psoriasis

Gordon, K. B., Langley, R. G., Gottlieb, A. B., Papp, K. A., Krueger, G. G., Strober, B. E., Williams, D. A., Gu, Y., & Valdes, J. M. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.304 · Cited by 168

Fine-tuning of dendritic cell biology by the TNF superfamily

deLuca, L. S., & Gommerman, J. L. (2012) · Nature reviews. Immunology · doi:10.1038/nri3193 · Cited by 164

IL-1RL2 and Its Ligands Contribute to the Cytokine Network in Psoriasis

Blumberg, H., Dinh, H., Dean, C., Trueblood, E. S., Bailey, K., Shows, D., Bhagavathula, N., Aslam, M. N., Varani, J., Towne, J. E., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000313 · Cited by 161

Effective narrow-band UVB radiation therapy suppresses the IL-23/IL-17 axis in normalized psoriasis plaques

Johnson-Huang, L. M., Suárez-Fariñas, M., Sullivan-Whalen, M., Gilleaudeau, P., Krueger, J. G., & Lowes, M. A. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.166 · Cited by 160

Supplementary Materials for Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis

Hueber, W., Patel, D. D., Dryja, T. P., Wright, A., Bruin, G. J. M., Antoni, C., Gold, M. H., Durez, P., Tak, P. P., Go, J. J., et al. (2010) · Cited by 151

Efficacy and safety results from a phase III, randomized controlled trial comparing the safety and efficacy of briakinumab with etanercept and placebo in patients with moderate to severe chronic plaque psoriasis

Strober, B. E., Crowley, J., Yamauchi, P. S., et al. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10419.x · Cited by 146

Human Keratinocytes' Response to Injury Upregulates CCL20 and Other Genes Linking Innate and Adaptive Immunity

Crispin, M. K., Billick, E., Mitsui, H., Gulati, N., Fujita, H., Gilleaudeau, P., Sullivan-Whalen, M. M., Johnson-Huang, L. M., Suárez‐Fariñas, M., & Krueger, J. G. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.262 · Cited by 146

Anti-IL-17 Receptor Antibody AMG 827 Leads to Rapid Clinical Response in Subjects with Moderate to Severe Psoriasis: Results from a Phase I, Randomized, Placebo-Controlled Trial

Papp, K. A., Reid, C., Foley, P. A., Sinclair, R. D., Salinger, D. H., Williams, G., Dong, H., Krueger, J. G., Russell, C. B., & Martin, D. A. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.163 · Cited by 143

A Single Intradermal Injection of IFN-γ Induces an Inflammatory State in Both Non-Lesional Psoriatic and Healthy Skin

Johnson-Huang, L. M., Suárez‐Fariñas, M., Pierson, K. C., Fuentes‐Duculan, J., Cueto, I., Lentini, T., Sullivan-Whalen, M. M., Gilleaudeau, P., Krueger, J. G., Haider, A. S., et al. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.458 · Cited by 120

Cytokine-Producing Dendritic Cells in the Pathogenesis of Inflammatory Skin Diseases

Johnson-Huang, L. M., McNutt, N. S., Krueger, J. G., & Lowes, M. A. (2009) · Journal of Clinical Immunology · doi:10.1007/s10875-009-9278-8 · Cited by 107

Identification of TNF-related apoptosis-inducing ligand and other molecules that distinguish inflammatory from resident dendritic cells in patients with psoriasis

Zaba, L. C., Fuentes‐Duculan, J., Eungdamrong, N. J., Johnson-Huang, L. M., Nograles, K. E., White, T. R., Pierson, K. C., Lentini, T., Suárez‐Fariñas, M., Lowes, M. A., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.03.018 · Cited by 106

Heterogeneity of Inflammatory and Cytokine Networks in Chronic Plaque Psoriasis

Swindell, W. R., Xing, X., Stuart, P. E., Chen, C. S., Aphale, A., Nair, R. P., Voorhees, J. J., Elder, J. T., Johnston, A. W. B., & Gudjonsson, J. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034594 · Cited by 96

Cathelicidin LL‐37: a defense molecule with a potential role in psoriasis pathogenesis

Dombrowski, Y., & Schauber, J. (2012) · Experimental Dermatology · doi:10.1111/j.1600-0625.2012.01459.x · Cited by 94

Apilimod Inhibits the Production of IL-12 and IL-23 and Reduces Dendritic Cell Infiltration in Psoriasis

Wada, Y., Cardinale, I. R., Khatcherian, A., Chu, J., Kantor, A. B., Gottlieb, A. B., Tatsuta, N., Jacobson, E. W., Barsoum, J., & Krueger, J. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035069 · Cited by 80

Expression of interleukin (IL)-1 family members upon stimulation with IL-17 differs in keratinocytes derived from patients with psoriasis and healthy donors

Muhr, P., Zeitvogel, J., Heitland, I., Werfel, T., & Wittmann, M. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10302.x · Cited by 78

IL ‐17: A new actor in IFN ‐driven systemic autoimmune diseases

Ambrosi, A., Espinosa, A., & Wahren‐Herlenius, M. (2012) · European Journal of Immunology · doi:10.1002/eji.201242653 · Cited by 77

Psoriasis genomics: analysis of proinflammatory (type 1) gene expression in large plaque (Western) and small plaque (Asian) psoriasis vulgaris

Lew, W., Lee, E.-Y., & Krueger, J. G. (2004) · British Journal of Dermatology · doi:10.1111/j.0007-0963.2004.05891.x · Cited by 71

Tumor Necrosis Factor α-Mediated Induction of Interleukin 17C in Human Keratinocytes Is Controlled by Nuclear Factor κB

Johansen, C., Riis, J. L., Gedebjerg, A., Kragballe, K., & Iversen, L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.240671 · Cited by 67

A novel IL36RN/IL1F5 homozygous nonsense mutation, p.Arg10X, in a Japanese patient with adult-onset generalized pustular psoriasis

Sugiura, K., Takeichi, T., Kono, M., Ogawa, Y., Shimoyama, Y., Muro, Y., & Akiyama, M. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.10953.x · Cited by 64

Development and function of interleukin 17–producing γδ T cells

Korn, T., & Petermann, F. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06355.x · Cited by 64

Development and function of intestinal innate lymphoid cells

Cherrier, M., Ohnmacht, C., Cording, S., & Eberl, G. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.03.011 · Cited by 55

Tissue and blood superoxide dismutase activities and malondialdehyde levels in different clinical severities of acne vulgaris

Fattah, N. S. A. A., Shaheen, M. A., Ebrahim, A. A., & okda, E. S. E. E. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08770.x · Cited by 50

Psoriasis increased the risk of diabetes: a meta-analysis

Cheng, J., Kuai, D., Zhang, L., Yang, X., & Qiu, B. (2011) · Archives of Dermatological Research · doi:10.1007/s00403-011-1200-6 · Cited by 46

Immunology of Psoriasis

Lowes, M. A., Suárez-Fariñas, M., & Krueger, J. G. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120225 · Cited by 1,650

IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases

Teng, M. W. L., Bowman, E. P., McElwee, J. J., Smyth, M. J., Casanova, J.-L., Cooper, A. M., & Cua, D. J. (2015) · Nature Medicine · doi:10.1038/nm.3895 · Cited by 873

Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis

Guttman-Yassky, E., Bissonnette, R., Ungar, B., Suárez-Fariñas, M., Ardeleanu, M., Esaki, H., Suprun, M., Estrada, Y., Xu, H., Peng, X., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.08.022 · Cited by 697

Advances in the pathogenesis of psoriasis: from keratinocyte perspective

Zhou, X., Chen, Y., Cui, L., Shi, Y., & Guo, C. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-04523-3 · Cited by 632

The Interplay Between Keratinocytes and Immune Cells in the Pathogenesis of Psoriasis

Albanesi, C., Madonna, S., Gisondi, P., & Girolomoni, G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01549 · Cited by 432